Advanced precision microsampling for COVID-19 research

Part number: CO-0119-G

Image is representative (may not be specific item).

Download: Advanced precision microsampling for COVID-19 research [PDF]

hemaPEN^® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.

Collections: All, Brochures, hemaPEN (all), Literature - All, Literature - Health, Microsampling, Sampling, Support Items

Category: 498100000, 498100010, ARTG, ARTG 280007, Australia, Australian Register of Therapeutic Goods, Biomarkers, Biomonitoring, Blood, Clinical, Coronavirus, COVID-19, DBS, Health, hemaPEN, Histology, Life, Microsampling, New Zealand, Pathology, Pharmaceutical, Research, Sample collection, Sampling, Serology, Support, TGA, Therapeutic Goods Administration, Vaccines